Literature DB >> 7589856

The ob gene and insulin. A relationship leading to clues to the understanding of obesity.

I Cusin1, A Sainsbury, P Doyle, F Rohner-Jeanrenaud, B Jeanrenaud.   

Abstract

Obesity and non-insulin-dependent diabetes are estimated to affect millions of people in the world. This pathology is multifactorial, comprising complex interactions of genetic and environmental factors and lacking a specific therapy. Great interest arose from the recent discovery of the ob gene expressed only in adipose tissue and coding for a protein that appears to regulate adiposity, potentially by acting as a satiety factor. We report here that in normal rats, ob mRNA is respectively up- or downregulated by a rise in insulinemia (induced by 2-day insulin infusion while maintaining euglycemia) or a decrease in insulinemia (induced by a 3-day fast). Our results also show that in genetically obese fa/fa rats studied longitudinally, white adipose tissue ob mRNA levels increase in parallel with early occurring and steadily increasing hyperinsulinemia. This results in adult obese animals having markedly higher ob mRNA levels than age-matched normoinsulinemic lean rats. Furthermore, in adult obese rats, ob mRNA escapes down-regulation as normalization of hyperinsulinemia due to fasting fails to reduce the high ob mRNA levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7589856     DOI: 10.2337/diab.44.12.1467

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

Review 1.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

2.  Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects.

Authors:  G Boden; X Chen; J W Kolaczynski; M Polansky
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  Rapid decrease of leptin in middle-aged sedentary individuals after 20 minutes of vigorous exercise with early recovery after the termination of the test.

Authors:  I N Legakis; T Mantzouridis; A Saramantis; E Lakka-Papadodima
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

4.  Impact of maternal undernutrition on hypothalamo-pituitary-adrenal axis and adipocyte functions in male rat offspring.

Authors:  A N Chisari; A Giovambattista; M Perello; E Spinedi
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

Review 5.  Regulation of circulating leptin in humans.

Authors:  B Ahrén; H Larsson; C Wilhelmsson; B Näsman; T Olsson
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

6.  Insulin and insulin-like growth factor 1 antagonize the stimulation of ob gene expression by dexamethasone in cultured rat adipose tissue.

Authors:  B A Reul; L N Ongemba; A M Pottier; J C Henquin; S M Brichard
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

7.  Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study.

Authors:  P Zimmet; A Hodge; M Nicolson; M Staten; M de Courten; J Moore; A Morawiecki; J Lubina; G Collier; G Alberti; G Dowse
Journal:  BMJ       Date:  1996-10-19

8.  The hypotriglyceridemic effect of dietary n-3 FA is associated with increased beta-oxidation and reduced leptin expression.

Authors:  J Ukropec; J E Reseland; D Gasperikova; E Demcakova; L Madsen; R K Berge; A C Rustan; I Klimes; C A Drevon; E Sebökova
Journal:  Lipids       Date:  2003-10       Impact factor: 1.880

9.  Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses.

Authors:  K I Melkersson; M-L Dahl
Journal:  Psychopharmacology (Berl)       Date:  2003-07-08       Impact factor: 4.530

10.  Early and late stimulation of ob mRNA expression in meal-fed and overfed rats.

Authors:  R B Harris; T G Ramsay; S R Smith; R C Bruch
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.